Results 21 to 30 of about 4,306 (118)

Characterizing Symptoms and Identifying Biomarkers of Long COVID in People With and Without HIV: Protocol for a Remotely Conducted Prospective Observational Cohort Study

open access: yesJMIR Research Protocols, 2023
BackgroundLiving with HIV is a risk factor for severe acute COVID-19, but it is unknown whether it is a risk factor for long COVID.
Nuria Gallego Márquez   +10 more
doaj   +1 more source

Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study

open access: yesNeuropsychopharmacology Reports, 2020
Objective To report the efficacy and safety of blonanserin in patients with schizophrenia compared with risperidone in a Japanese multicenter, randomized, double‐blind study based on post hoc sensitivity analysis in addition to the previous results ...
Philip D. Harvey   +2 more
doaj   +1 more source

Impact of yoga in a case of vocal cord dysfunction with dysautonomia

open access: yesInternational Journal of Yoga, 2017
A 23-year-old female with a past medical history of gastroesophageal reflux disease presented with shortness of breath induced by exercise and certain odors.
Rozina Wadhwania
doaj   +1 more source

Effect of Postural Changes on Leg Muscle Tone and Arterial Blood Pressure in Able‑Bodied People and People after Chronic Spinal Cord Injury

open access: yesBaltic Journal of Sport and Health Sciences, 2018
Research  background  and  hypothesis.  Following  spinal  cord  injury  part  of  sympathetic  nervous  system is  disrupted  from  the  brain  stem  control,  which  results  in  cardiovascular  system  regulation  disorders.  Impaired cardiovascular
Aušrinė Packevičiūtė   +2 more
doaj   +1 more source

Regional Implementation of a Pediatric Cardiology Syncope Algorithm Using Standardized Clinical Assessment and Management Plans (SCAMPS) Methodology

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundPediatric syncope is common. Cardiac causes are rarely found. We describe and assess a pragmatic approach to these patients first seen by a pediatric cardiologist in the New England region, using Standardized Clinical Assessment and Management ...
Yvonne Paris   +9 more
doaj   +1 more source

Abdominal Compartment Syndrome Secondary to Chronic Constipation

open access: yesCase Reports in Pediatrics, 2011
Abdominal compartment syndrome (ACS) is defined as an elevated intraabdominal pressure with evidence of organ dysfunction. The majority of published reports of ACS are in neonates with abdominal wall defects and in adults following trauma or burns, but ...
Helene Flageole   +3 more
doaj   +1 more source

A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336

open access: yesFrontiers in Pharmacology, 2018
Background: Preclinical and clinical data suggest that a compound which binds potently to and inhibits the dopamine transporter, but with a slower onset and offset rate than cocaine and with less abuse potential and psychomotor stimulant activity, could ...
F. Ivy Carroll   +4 more
doaj   +1 more source

Fall Risk Assessment Experience

open access: yesMedEdPORTAL, 2010
Falls are common in older adults and result in significant morbidity, including injury, pain, disability, and even death. Risk factors for falling have been identified, and interventions to improve these risk factors have been found to reduce fall rates ...
Sara Bradley, Reena Karani
doaj   +1 more source

Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT‐1186‐A02)

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims An On/Off dosing regimen of intravenous (IV) edaravone and edaravone oral suspension is approved in the US for the treatment of amyotrophic lateral sclerosis (ALS). Placebo‐controlled clinical trials showed IV edaravone slows the rate of physical functional decline.
Jeffrey Rothstein   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy